News
Drop in pay-for-delay good for access to medicines in Europe8 July 2011 – The European Commission revealed a fall in problematic medicines patent settlements. The latest results from DG Competition’s second monitoring exercise show that damaging ‘pay-for-delay’ settlements fell from an average of 22% of all patent settlements (2000 and 2008) to just 3% in 2010. This is good news for access to medicines…Continue reading HAI Europe statement
Publications
08 July 2011Statement on Drop in pay-for-delay good for access to medicines
25 May 2011
HAI Europe Consultation Response to DG Enterprise on the Transparency Directive
31 Mar 2011
HAI Europe Response to DG Internal Market Consultation on the IP RED Directive
31 Jan 2009
HAI Europe Response to DG Competition Consultation on European Pharmaceutical Industry